Texas Roadhouse Insider Sale: 3,153 Shares Sold; 4,000 RSUs Scheduled to Vest
Rhea-AI Filing Summary
Regina A. Tobin, President of Texas Roadhouse, Inc. (TXRH), reported a sale and outstanding restricted stock units. On 08/18/2025 she sold 3,153 shares of TXRH common stock at a weighted average sale price of $173.53, leaving 15,261 shares reported as beneficially owned. The filing also shows 4,000 restricted stock units that represent rights to receive one share each; those RSUs vest and will be delivered on January 8, 2026 subject to continued service. The Form 4 was signed by an attorney-in-fact on 08/20/2025.
Positive
- Transaction was timely and clearly disclosed with date, quantity, and weighted average price provided
- RSU vesting schedule is explicit: 4,000 restricted stock units vest and are deliverable on January 8, 2026 subject to continued service
Negative
- Insider disposed of 3,153 shares on 08/18/2025, reducing direct beneficial ownership to 15,261 shares
Insights
TL;DR: Insider sale of 3,153 shares was disclosed; remaining holdings and scheduled RSU vesting are clearly reported.
The transaction is a routine insider disposition recorded on 08/18/2025 at a weighted average price of $173.53, reducing the reporting persons direct holdings to 15,261 shares. The filing also documents 4,000 restricted stock units that vest on 01/08/2026 and will convert into common shares upon delivery. From a trading-impact perspective this is a single, disclosed sale with explicit vesting details; there are no additional financial metrics or company guidance in the filing to assess broader operational impact.
TL;DR: Disclosure meets Section 16 reporting: sale reported and future equity awards timed and documented.
The Form 4 identifies Regina A. Tobin as President and an officer of TXRH and records the sale and outstanding RSUs with vesting conditions tied to continued service. The form is signed by a power of attorney, indicating standard filing process. The document provides clear dates, quantities, and the weighted average sale price, satisfying required transparency for insider transactions. No amendments or additional contingent arrangements are disclosed.